Skip to main content
Erschienen in: Current Osteoporosis Reports 1/2012

01.03.2012 | Current Therapeutics (SL Silverman, Section Editor)

Assessment of Fracture Risk

verfasst von: Sanford Baim, William D. Leslie

Erschienen in: Current Osteoporosis Reports | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Osteoporosis-related fractures (low-trauma, fragility fractures) are associated with significant morbidity, mortality, and health care expenditure worldwide. In the absence of a defining fracture, the diagnosis of osteoporosis is based on the World Health Organization’s T-score criteria using central dual-energy x-ray absorptiometry (DXA). Paradoxically, the majority of those patients who will sustain a low-trauma fracture do not meet the T-score definition of osteoporosis. Conversely, younger individuals with bone density in the osteoporotic range but no other risk factors have relatively low fracture rates and yet are frequently considered candidates for osteoporosis therapies. The limited accuracy of bone density testing alone to predict fractures has led to the development of a variety of fracture assessment tools that utilize the combination of bone density and clinical risk factors to improve the prediction of low-trauma fractures. These fracture assessment tools quantitatively predict the 10-year fracture probability of hip and major osteoporosis-related fractures, and can be used to define cost-effective intervention strategies for primary and secondary fracture prevention.
Literatur
1.
Zurück zum Zitat •• National Osteoporosis Foundation, Clinician’s Guide to prevention and treatment of osteoporosis. 2008; available at http//nof.org/professionals/NOF_clinicians_Guide pdf, accessed February 12, 2011. The NOF Clinician’s Guide to prevention and treatment of osteoporosis serves as a basic reference for the evaluation and treatment of osteoporosis in the United States. •• National Osteoporosis Foundation, Clinician’s Guide to prevention and treatment of osteoporosis. 2008; available at http//nof.org/professionals/NOF_clinicians_Guide pdf, accessed February 12, 2011. The NOF Clinician’s Guide to prevention and treatment of osteoporosis serves as a basic reference for the evaluation and treatment of osteoporosis in the United States.
2.
Zurück zum Zitat Kanis JA. 2007 WHO Technical Report, University of Sheffield, UK:66. Kanis JA. 2007 WHO Technical Report, University of Sheffield, UK:66.
3.
Zurück zum Zitat Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726.PubMedCrossRef Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726.PubMedCrossRef
4.
Zurück zum Zitat Gullber B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407.CrossRef Gullber B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407.CrossRef
6.
Zurück zum Zitat Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;3:465–75. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;3:465–75.
7.
Zurück zum Zitat World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. Geneva: WHO; 1994. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. Geneva: WHO; 1994.
8.
Zurück zum Zitat Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:17-1141. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:17-1141.
9.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Jonsson B, et al. Risk of hip fracture according to the World Health Organization criteria for osteoporosis and osteopenia. Bone. 2000;27:585–90.PubMedCrossRef Kanis JA, Johnell O, Oden A, Jonsson B, et al. Risk of hip fracture according to the World Health Organization criteria for osteoporosis and osteopenia. Bone. 2000;27:585–90.PubMedCrossRef
10.
Zurück zum Zitat World Health Organization Guidelines for preclinical evaluation and clinical trials in osteoporosis. Geneva: WHO; 1998. World Health Organization Guidelines for preclinical evaluation and clinical trials in osteoporosis. Geneva: WHO; 1998.
11.
Zurück zum Zitat Marshall D, Johnell O, Edel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–59.PubMedCrossRef Marshall D, Johnell O, Edel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–59.PubMedCrossRef
12.
Zurück zum Zitat Cooper C, Aihie A. Osteoporosis: recent advances in pathogenesis and treatment. Q J Med. 1994;87:203–9.PubMed Cooper C, Aihie A. Osteoporosis: recent advances in pathogenesis and treatment. Q J Med. 1994;87:203–9.PubMed
13.
Zurück zum Zitat Kanis JA, Borgstrom F, De laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581–9.PubMedCrossRef Kanis JA, Borgstrom F, De laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581–9.PubMedCrossRef
14.
Zurück zum Zitat Lewiecki EM, Compston JE, Miller PD, et al. 2010 Official Positions for FRAX® Bone Mineral Density and FRAX® Simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom. 2011;14:226–36.PubMedCrossRef Lewiecki EM, Compston JE, Miller PD, et al. 2010 Official Positions for FRAX® Bone Mineral Density and FRAX® Simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom. 2011;14:226–36.PubMedCrossRef
15.
Zurück zum Zitat Leslie WD, Tsang JF, Caetano PA, et al. Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab. 2007;92(1):77–81.PubMedCrossRef Leslie WD, Tsang JF, Caetano PA, et al. Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab. 2007;92(1):77–81.PubMedCrossRef
16.
Zurück zum Zitat Wainwright SA, Marshall LM, Ensrud KE, et al. Study of Osteoporotic Fractures Research Group. Hip fractures in women without osteoporosis. J Clin Endocrinol Metab. 2005;90(5):2787–93.PubMedCrossRef Wainwright SA, Marshall LM, Ensrud KE, et al. Study of Osteoporotic Fractures Research Group. Hip fractures in women without osteoporosis. J Clin Endocrinol Metab. 2005;90(5):2787–93.PubMedCrossRef
17.
Zurück zum Zitat Pasco JA, Seeman E, Henry MJ, et al. The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int. 2006;17(9):1404–9.PubMedCrossRef Pasco JA, Seeman E, Henry MJ, et al. The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int. 2006;17(9):1404–9.PubMedCrossRef
18.
Zurück zum Zitat Sornay-Rendu E, Muoz F, Garnero P, et al. Identification of osteopenic women at high risk of fracture. The OFELY study. J Bone Miner Res. 2005;20(10):1813–19.PubMedCrossRef Sornay-Rendu E, Muoz F, Garnero P, et al. Identification of osteopenic women at high risk of fracture. The OFELY study. J Bone Miner Res. 2005;20(10):1813–19.PubMedCrossRef
19.
Zurück zum Zitat Alonso-Coello P, García-Franco AL, Guyatt G, et al. Drugs for pre-osteoporosis: prevention or disease mongering? BMJ 2008;19;336(7636):126–9. Alonso-Coello P, García-Franco AL, Guyatt G, et al. Drugs for pre-osteoporosis: prevention or disease mongering? BMJ 2008;19;336(7636):126–9.
20.
Zurück zum Zitat Lewiecki M. Risk communication and shared decision making in the care of patients with osteoporosis. J Clin Densitom. 2010;13(4):335–45.PubMedCrossRef Lewiecki M. Risk communication and shared decision making in the care of patients with osteoporosis. J Clin Densitom. 2010;13(4):335–45.PubMedCrossRef
21.
Zurück zum Zitat Woloshin S, Schwartz LM. Communicating data about the benefits and harms of treatment a randomized trial. Ann Intern Med. 2011;155:87–96.PubMed Woloshin S, Schwartz LM. Communicating data about the benefits and harms of treatment a randomized trial. Ann Intern Med. 2011;155:87–96.PubMed
22.
Zurück zum Zitat Leslie WD. Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int. 2008;19:459–63.PubMedCrossRef Leslie WD. Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int. 2008;19:459–63.PubMedCrossRef
23.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H, et al. Development and use of FRAX® in osteoporosis. Osteoporos Int. 2010;21(Suppl2):S407–13.PubMedCrossRef Kanis JA, McCloskey EV, Johansson H, et al. Development and use of FRAX® in osteoporosis. Osteoporos Int. 2010;21(Suppl2):S407–13.PubMedCrossRef
24.
Zurück zum Zitat Papaionnou A, Morin S, Cheung AM, et al. 2010 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182(17):1864–73.CrossRef Papaionnou A, Morin S, Cheung AM, et al. 2010 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182(17):1864–73.CrossRef
25.
Zurück zum Zitat Hamdy RC, Baim S, Broy SB. Algorithm for the management of osteoporosis. SMJ. 2010;103(10):1009–15.CrossRef Hamdy RC, Baim S, Broy SB. Algorithm for the management of osteoporosis. SMJ. 2010;103(10):1009–15.CrossRef
29.
Zurück zum Zitat Hippisley-Cox J, Copuland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 2009;339:b4229 available at http://www.qfracture.org/, accessed February 24, 2011. Hippisley-Cox J, Copuland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 2009;339:b4229 available at http://​www.​qfracture.​org/​, accessed February 24, 2011.
30.
Zurück zum Zitat Kanis JA on behalf of the World Health Organization Scientific Group a, Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. 2008, available at http://www.shef.ac.uk/FRAX/index.htm, accessed February 24, 2011. Kanis JA on behalf of the World Health Organization Scientific Group a, Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. 2008, available at http://​www.​shef.​ac.​uk/​FRAX/​index.​htm, accessed February 24, 2011.
31.
Zurück zum Zitat Oden A, Johansson H, McCloskey EV. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–97.PubMedCrossRef Oden A, Johansson H, McCloskey EV. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–97.PubMedCrossRef
32.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–97.PubMedCrossRef Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–97.PubMedCrossRef
33.
Zurück zum Zitat •• Hans D, Kanis J, Baim S, et al. Joint official positions of the International Society for Clinical Densitometry (ISCD) and International Osteoporosis Foundation (IOF) on FRAX®: Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice. J Clin Densitom 2011;14(3):171–80. The joint Official Positions of the ISCD and IOF are the most updated and accepted guidelines for quantitatively or qualitatively adjusting FRAX CRFs and subsequent fracture probabilities for the individual patient. PubMedCrossRef •• Hans D, Kanis J, Baim S, et al. Joint official positions of the International Society for Clinical Densitometry (ISCD) and International Osteoporosis Foundation (IOF) on FRAX®: Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice. J Clin Densitom 2011;14(3):171–80. The joint Official Positions of the ISCD and IOF are the most updated and accepted guidelines for quantitatively or qualitatively adjusting FRAX CRFs and subsequent fracture probabilities for the individual patient. PubMedCrossRef
34.
Zurück zum Zitat •• Kanis J, Hans D, Cooper C, et al. Interpretation and use of FRAX® in clinical practice. Osteoporos Int 2011;22(9):2395–411. The joint Official Positions of the ISCD and IOF are the most updated and accepted guidelines for quantitatively or qualitatively adjusting FRAX CRFs and subsequent fracture probabilities for the individual patient. PubMedCrossRef •• Kanis J, Hans D, Cooper C, et al. Interpretation and use of FRAX® in clinical practice. Osteoporos Int 2011;22(9):2395–411. The joint Official Positions of the ISCD and IOF are the most updated and accepted guidelines for quantitatively or qualitatively adjusting FRAX CRFs and subsequent fracture probabilities for the individual patient. PubMedCrossRef
36.
Zurück zum Zitat Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033–46.PubMedCrossRef Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033–46.PubMedCrossRef
37.
Zurück zum Zitat Kanis JA, Johnell O, De Laet C, et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237–44.PubMedCrossRef Kanis JA, Johnell O, De Laet C, et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237–44.PubMedCrossRef
38.
Zurück zum Zitat Cooper C, Cole ZA, Holroyd CR, et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011;22(5):1277–88.PubMedCrossRef Cooper C, Cole ZA, Holroyd CR, et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011;22(5):1277–88.PubMedCrossRef
39.
Zurück zum Zitat Leslie WD, Lix LM. Effects of FRAX® model calibration on intervention rates: a simulation study. J Clin Densitom. 2011;14(3):272–8.PubMedCrossRef Leslie WD, Lix LM. Effects of FRAX® model calibration on intervention rates: a simulation study. J Clin Densitom. 2011;14(3):272–8.PubMedCrossRef
40.
Zurück zum Zitat Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Springer (New York); 2008. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Springer (New York); 2008.
41.
Zurück zum Zitat • Leslie WD, Lix LM, Langsetmo L, et al. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 2011;22:817–27. This describes the creation of a FRAX model for fracture assessment in Canadian men and women.PubMedCrossRef • Leslie WD, Lix LM, Langsetmo L, et al. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 2011;22:817–27. This describes the creation of a FRAX model for fracture assessment in Canadian men and women.PubMedCrossRef
42.
Zurück zum Zitat Leslie WD, Lix LM, Johansson H, et al. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res. 2010;25(11):2350–8.PubMedCrossRef Leslie WD, Lix LM, Johansson H, et al. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res. 2010;25(11):2350–8.PubMedCrossRef
43.
Zurück zum Zitat Fraser L-A, Langsetmo L, Berger C, et al. Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos. Osteoporos Int. 2011;22:829–37.PubMedCrossRef Fraser L-A, Langsetmo L, Berger C, et al. Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos. Osteoporos Int. 2011;22:829–37.PubMedCrossRef
46.
Zurück zum Zitat Watts NB, Siris ES, Cummings SR, Bauer DC. Perspective: Filtering FRAX®. Osteoporos Int. 2010;21:537–41.PubMedCrossRef Watts NB, Siris ES, Cummings SR, Bauer DC. Perspective: Filtering FRAX®. Osteoporos Int. 2010;21:537–41.PubMedCrossRef
47.
Zurück zum Zitat McCloskey E, Compston J, Cooper C. The US FRAX® filter: avoiding confusion or hindering progress? Osteoporos Int. 2010;21:885.PubMedCrossRef McCloskey E, Compston J, Cooper C. The US FRAX® filter: avoiding confusion or hindering progress? Osteoporos Int. 2010;21:885.PubMedCrossRef
48.
Zurück zum Zitat •• National Osteoporosis Guideline Group (NOGG). Osteoporosis: clinical guidelines for prevention and treatment Executive Summary. 2010. The UK NOGG assessment and diagnosis of osteoporosis and therapeutic agents available for treatment provides different management strategies for the prevention and treatment of osteoporotic fractures in postmenopausal women and men over 50 years of age. •• National Osteoporosis Guideline Group (NOGG). Osteoporosis: clinical guidelines for prevention and treatment Executive Summary. 2010. The UK NOGG assessment and diagnosis of osteoporosis and therapeutic agents available for treatment provides different management strategies for the prevention and treatment of osteoporotic fractures in postmenopausal women and men over 50 years of age.
49.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385–97.PubMedCrossRef Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385–97.PubMedCrossRef
50.
Zurück zum Zitat •• Kanis JA, McCloskey EV, Johansson H, et al. Case finding for the management of osteoporosis with FRAX®-assessment and intervention thresholds for the UK. Osteoporos Int 2008;19:1395–408. The use of a case-finding strategy for the management of osteoporosis with FRAX reviews the use of FRAX as a screening tool with and without bone density testing for the treatment of osteoporosis in the United Kingdom.PubMedCrossRef •• Kanis JA, McCloskey EV, Johansson H, et al. Case finding for the management of osteoporosis with FRAX®-assessment and intervention thresholds for the UK. Osteoporos Int 2008;19:1395–408. The use of a case-finding strategy for the management of osteoporosis with FRAX reviews the use of FRAX as a screening tool with and without bone density testing for the treatment of osteoporosis in the United Kingdom.PubMedCrossRef
51.
Zurück zum Zitat Donaldson MG, Cawthon PM, Lui LY, et al. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2009;24:675–80.PubMedCrossRef Donaldson MG, Cawthon PM, Lui LY, et al. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2009;24:675–80.PubMedCrossRef
52.
Zurück zum Zitat Dawson-Hughes B, Looker AC, Tosteson AN, et al. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporos Int. 2010;21(1):41–52.PubMedCrossRef Dawson-Hughes B, Looker AC, Tosteson AN, et al. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporos Int. 2010;21(1):41–52.PubMedCrossRef
53.
Zurück zum Zitat •• Papaioannou A, Morin S, Cheung AM, et al. for the Scientific Advisory Council of Osteoporosis Canada. 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. Can Med Assoc J 2010;182(17):1864–73. The Canadian Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada reviews the use of the FRAX model in Canada in contrast to US and UK Osteoporosis Guidelines.CrossRef •• Papaioannou A, Morin S, Cheung AM, et al. for the Scientific Advisory Council of Osteoporosis Canada. 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. Can Med Assoc J 2010;182(17):1864–73. The Canadian Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada reviews the use of the FRAX model in Canada in contrast to US and UK Osteoporosis Guidelines.CrossRef
54.
Zurück zum Zitat Leslie WD, Berger C, Langsetmo L, Adachi JD, et al. CaMos Research Group. Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba BMD cohorts. Osteoporos Int. 2011;22:1873–83.PubMedCrossRef Leslie WD, Berger C, Langsetmo L, Adachi JD, et al. CaMos Research Group. Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba BMD cohorts. Osteoporos Int. 2011;22:1873–83.PubMedCrossRef
55.
Zurück zum Zitat Leslie WD, Morin S. Fracture burden in relation to low bone mineral density and FRAX® probability. J Clin Densitom. 2011;14(3):279–85.PubMedCrossRef Leslie WD, Morin S. Fracture burden in relation to low bone mineral density and FRAX® probability. J Clin Densitom. 2011;14(3):279–85.PubMedCrossRef
56.
Zurück zum Zitat Leslie WD, Morin S, Lix LM, et al. Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporosis International 2011; August 18 [Epub ahead of print]. Leslie WD, Morin S, Lix LM, et al. Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporosis International 2011; August 18 [Epub ahead of print].
57.
Zurück zum Zitat Preventive Services US. Task Force. Screening for osteoporosis: U.S.Preventive services task force recommendation statement. Ann Intern Med. 2011;154(5):356–64. Preventive Services US. Task Force. Screening for osteoporosis: U.S.Preventive services task force recommendation statement. Ann Intern Med. 2011;154(5):356–64.
58.
Zurück zum Zitat Kanis JA, McCloskey E, Johansson H, et al. FRAX® with and without BMD. Calcified Tissue International 2011; [Epub ahead of print]. Kanis JA, McCloskey E, Johansson H, et al. FRAX® with and without BMD. Calcified Tissue International 2011; [Epub ahead of print].
59.
Zurück zum Zitat Leslie WD, Morin S. Fracture burden in relation to low bone mineral density and FRAX® probability. J Clin Densitom. 2011;14(3):279–85.PubMedCrossRef Leslie WD, Morin S. Fracture burden in relation to low bone mineral density and FRAX® probability. J Clin Densitom. 2011;14(3):279–85.PubMedCrossRef
60.
Zurück zum Zitat Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA. A comparative study of using non hip bone density inputs with FRAX®. Osteoporos Int 2011;Oct 19. [Epub ahead of print]. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA. A comparative study of using non hip bone density inputs with FRAX®. Osteoporos Int 2011;Oct 19. [Epub ahead of print].
64.
Zurück zum Zitat Kanis JA, Johansson H, Oden A, et al. Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int. 2011;22:809–16.PubMedCrossRef Kanis JA, Johansson H, Oden A, et al. Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int. 2011;22:809–16.PubMedCrossRef
65.
Zurück zum Zitat Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res. 2010;62(11):1515–26.CrossRef Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res. 2010;62(11):1515–26.CrossRef
66.
Zurück zum Zitat Kanis article above, van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology: (Oxford) 2000;39:1383–89. Kanis article above, van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology: (Oxford) 2000;39:1383–89.
67.
Zurück zum Zitat Reid DM, Hughes RA, Laan RFJM, et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial. J Bone Miner Res. 2000;15(6):1006–13.PubMedCrossRef Reid DM, Hughes RA, Laan RFJM, et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial. J Bone Miner Res. 2000;15(6):1006–13.PubMedCrossRef
68.
Zurück zum Zitat Michel BA, Bloch DA, Wolfe F, et al. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. The J of Rheum. 1993;20(10):1666–9. Michel BA, Bloch DA, Wolfe F, et al. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. The J of Rheum. 1993;20(10):1666–9.
69.
Zurück zum Zitat Reid IR. Glucocorticoid osteoporosis-mechanisms and management. Eur J of Endocrin. 1997;137:209–17.CrossRef Reid IR. Glucocorticoid osteoporosis-mechanisms and management. Eur J of Endocrin. 1997;137:209–17.CrossRef
70.
Zurück zum Zitat Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Annals of the Rheum Dis. 1995;54:49–52.CrossRef Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Annals of the Rheum Dis. 1995;54:49–52.CrossRef
71.
Zurück zum Zitat De Vries F, Brache M, Leufkens HG, et al. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. 2007;56:208–14.PubMedCrossRef De Vries F, Brache M, Leufkens HG, et al. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. 2007;56:208–14.PubMedCrossRef
72.
Zurück zum Zitat Johnell O, Kanis JA, Oden A, Johansson H, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20:1185–94.PubMedCrossRef Johnell O, Kanis JA, Oden A, Johansson H, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20:1185–94.PubMedCrossRef
73.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone. 2008;42:467–75.PubMedCrossRef Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone. 2008;42:467–75.PubMedCrossRef
74.
Zurück zum Zitat Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468–89.PubMedCrossRef Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468–89.PubMedCrossRef
75.
Zurück zum Zitat Jones G, Nguyen T, Sambrook PN, Kelly PJ, et al. A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol. 1995;22:932–6.PubMed Jones G, Nguyen T, Sambrook PN, Kelly PJ, et al. A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol. 1995;22:932–6.PubMed
76.
Zurück zum Zitat Phillipov G, Phillips PJ. Skeletal site bone mineral density heterogeneity in women and men. Osteoporos Int. 2001;12:362–5.PubMedCrossRef Phillipov G, Phillips PJ. Skeletal site bone mineral density heterogeneity in women and men. Osteoporos Int. 2001;12:362–5.PubMedCrossRef
77.
Zurück zum Zitat Schneider DL, Bettencourt R, Barrett-Connor E. Clinical utility of spine bone density in elderly women. J Clin Densitom. 2006;9:255–60.PubMedCrossRef Schneider DL, Bettencourt R, Barrett-Connor E. Clinical utility of spine bone density in elderly women. J Clin Densitom. 2006;9:255–60.PubMedCrossRef
78.
Zurück zum Zitat Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom. 1999;2:343–50.PubMedCrossRef Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom. 1999;2:343–50.PubMedCrossRef
79.
Zurück zum Zitat Leslie WD, Lix LM, Tsang JF, et al. Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med 2007;1641–47. Leslie WD, Lix LM, Tsang JF, et al. Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med 2007;1641–47.
80.
Zurück zum Zitat Leslie WD, Lix LM. Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system. J Bone Miner Res. 2011;26:460–7.PubMedCrossRef Leslie WD, Lix LM. Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system. J Bone Miner Res. 2011;26:460–7.PubMedCrossRef
81.
Zurück zum Zitat Leslie WD, Lix LM, Johansson H, et al. Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int. 2011;22:839–47.PubMedCrossRef Leslie WD, Lix LM, Johansson H, et al. Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int. 2011;22:839–47.PubMedCrossRef
82.
Zurück zum Zitat Leslie WD, Kovacs CS, Olszynski WP, et al. Spine-Hip T-score difference predicts major osteoporositic fracture risk independent of FRAX®: a population-based report from CAMOS. J Clin Densitom. 2011;14(3):286–93.PubMedCrossRef Leslie WD, Kovacs CS, Olszynski WP, et al. Spine-Hip T-score difference predicts major osteoporositic fracture risk independent of FRAX®: a population-based report from CAMOS. J Clin Densitom. 2011;14(3):286–93.PubMedCrossRef
Metadaten
Titel
Assessment of Fracture Risk
verfasst von
Sanford Baim
William D. Leslie
Publikationsdatum
01.03.2012
Verlag
Current Science Inc.
Erschienen in
Current Osteoporosis Reports / Ausgabe 1/2012
Print ISSN: 1544-1873
Elektronische ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-011-0093-9

Weitere Artikel der Ausgabe 1/2012

Current Osteoporosis Reports 1/2012 Zur Ausgabe

Future Therapeutics (P Miller, Section Editor)

Oral Calcitonin

Future Therapeutics (P Miller, Section Editor)

Inhibition of Cathepsin K for Treatment of Osteoporosis

Current Therapeutics (SL Silverman, Section Editor)

Data from Extension Trials: Denosumab and Zoledronic Acid

Current Therapeutics (SL Silverman, Section Editor)

Secondary Fracture Prevention

Future Therapeutics (P Miller, Section Editor)

Sclerostin: Therapeutic Horizons Based Upon Its Actions

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.